Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Table 7 Comorbidity and ADR

Comorbidity	Number of patients	Patients with ADR	P value^#
Cancer	4	3 (75.0%)	0.006
Obesity	7	5 (71.4%)	0.001
Chronic kidney disease	38	19 (50.0%)	< 0.001
Cardiovascular diseases	58	23 (39.7%)	< 0.001
Hypertension	249	75 (30.1%)	< 0.001
Diabetes mellitus	157	46 (29.3%)	0.002
Chronic obstructive lung disease	4	1 (25.0%)	0.814
Asthma	47	10 (21.3%)	0.862

Patients with ADR are reported as n (%), where % is calculated by patients with ADR/number of patients
^#Analysed with Chi-square (X²) test

ISSN: 2052-3211